Device Trial Radar · NCT07321899
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,186
Planned (sponsor's estimate)
Start
Sep 11, 2026
Primary completion
Sep 2031
Study completion Apr 2041
Sponsor
- Lead sponsor
- Medtronic CardiovascularPublic (MDT)
- Sponsor type
- Industry
- First posted
- Jan 7, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.
Conditions
- Severe Tricuspid Regurgitation
Interventions
Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) SystemDevice
Transcatheter Tricuspid Valve Replacement
Edwards EVOQUE Tricuspid Valve Replacement (TTVR) SystemDevice
Transcatheter Tricuspid Valve Replacement
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of Major Adverse Events (MAE)Time frame: 30-days post-procedure
- Composite Endpoint: All-cause mortality, Heart failure hospitalization, and tricuspid valve reinterventionTime frame: 1-year post-procedure
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama at Birmingham (UAB) Hospital
Birmingham, Alabama · Recruiting
Abrazo Arizona Heart Hospital
Phoenix, Arizona · Recruiting
Cedars Sinai Medical Center
Los Angeles, California · Recruiting
17 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.